Benefits of AstraZeneca vaccine outweigh risks

Press/Media: Press / Media


This feature article and video highlight risk benefit modelling I performed addressing the risk of COVID-19 vaccine associated blood clots

Period22 Apr 2022

Media coverage


Media coverage

  • TitleBenefits of AstraZeneca vaccine outweigh risks
    Degree of recognitionLocal
    Media name/outletUWA News
    Media typeWeb
    DescriptionRisk versus benefit modelling by researchers at The University of Western Australia has weighed up the potential of harm from an extremely rare AstraZeneca vaccine blood clot complication against COVID-19 ICU admission from not being vaccinated.

    Associate Professor Matthew Linden from UWA’s School of Biomedical Sciences said the modelling had identified the implications for each adult age group of waiting out the months it might take Australia to secure further supplies of an alternative vaccine.
    PersonsMatthew Linden